Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 2700-30-3 | MDL No. : | MFCD00008867 |
Formula : | C7H15NO | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | UNBDDZDKBWPHAX-UHFFFAOYSA-N |
M.W : | 129.20 | Pubchem ID : | 75912 |
Synonyms : |
|
Num. heavy atoms : | 9 |
Num. arom. heavy atoms : | 0 |
Fraction Csp3 : | 0.86 |
Num. rotatable bonds : | 3 |
Num. H-bond acceptors : | 1.0 |
Num. H-bond donors : | 0.0 |
Molar Refractivity : | 39.25 |
TPSA : | 20.31 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.14 cm/s |
Log Po/w (iLOGP) : | 2.04 |
Log Po/w (XLOGP3) : | 1.34 |
Log Po/w (WLOGP) : | 1.26 |
Log Po/w (MLOGP) : | 1.63 |
Log Po/w (SILICOS-IT) : | 0.54 |
Consensus Log Po/w : | 1.36 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -1.29 |
Solubility : | 6.67 mg/ml ; 0.0516 mol/l |
Class : | Very soluble |
Log S (Ali) : | -1.37 |
Solubility : | 5.53 mg/ml ; 0.0428 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -0.77 |
Solubility : | 21.8 mg/ml ; 0.169 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 1.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.0 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
![]() |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
709 g | at 200℃; for 3 h; Autoclave | Formic acid, 255.7g (ie, 38.3g of water) and 99percent of diisopropylamine, 460g, with a purity of 85percent, are added to a 1-liter autoclave,The stirrer was started to mix well and a homogeneous reaction system was obtained. The molar ratio of formic acid to diisopropylamine is 1.05:1.While maintaining the stirring, the above homogeneous reaction system is heated up to about 200° C., the pressure in the autoclave rises to about 1.7 MPa and no longer increases, the reaction is maintained for about 3 hours, and the autoclave is vented and discharged. The carbon monoxide and water vapor were collected and the reaction product was collected to obtain about 709 g of a uniform and transparent solution. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
13 %Spectr. | Stage #1: With sodium hydride In N,N-dimethyl-formamide at 20℃; for 0.0833333 h; Sealed tube Stage #2: With diphenylsilane In N,N-dimethyl-formamide at 20℃; for 18 h; Sealed tube |
General procedure: 0.05mmol equivalent of poly-imidazolium, an equimolar amount of sodium hydride, and 2mL of anhydrous DMF were placed in a crimp-top vial (8mL). The vial was sealed, and the suspension was stirred for 2h before CO2 was introduced via a balloon. Amines (1mmol) were subsequently added, and the reaction mixture was then allowed to stir for 5min before 2.5 equivalents of silane were added. The reaction was allowed to stir for 18h. After the reaction was completed, the reaction mixture was centrifuged, a 400-μL aliquot was sampled, and 20μL of mesitylene was added. An aliquot was then taken for NMR spectroscopy. For catalyst recycling, the remaining solution was decanted, and 2mL of fresh DMF was added. The reaction was allowed to stir for 30min before centrifuging and removal of DMF. This procedure was repeated at least three times using DMF (1×) and dichloromethane (3×) as the washing solvent. The recovered catalyst was then dried under the Schlenk line, and used directly for the next run. |
[ 124172-53-8 ]
N,N'-(Hexane-1,6-diyl)bis(N-(2,2,6,6-tetramethylpiperidin-4-yl)formamide)
Similarity: 0.62
[ 835633-50-6 ]
4-(Hydroxymethyl)piperidine-1-carbaldehyde
Similarity: 0.57
[ 351329-88-9 ]
N-(3,5-Dimethyladamantan-1-yl)formamide
Similarity: 0.54